Skip to main content
Azra Borogovac, MD, Hematology, Irvine, CA

AzraBorogovacMDMS

Hematology Irvine, CA

Hematologic Oncology

Assistant Clinical Professor

Dr. Borogovac is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Borogovac's full profile

Already have an account?

  • Office

    1000 Fivepoint
    Irvine, CA 92618
    Phone+1 888-333-4673

Education & Training

  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Internal Medicine, 2015 - 2018
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 2015

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2022 - 2026
  • OK State Medical License
    OK State Medical License 2017 - 2022
  • MA State Medical License
    MA State Medical License 2015 - 2020
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Stroke and Myocardial Infarction (MI) in Hereditary Thrombotic Thrombocytopenic Purpura (HTTP): Similarities to Sickle Cell Anemia (SSA)
    Azra Borogovac, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • What Is Leukemia? Symptoms, Causes and Treatment
    What Is Leukemia? Symptoms, Causes and TreatmentJune 23rd, 2023
  • Cancer Is Now Leading Cause of Death Among HIV-Positive People, Report Says: ‘Of Great Concern’
    Cancer Is Now Leading Cause of Death Among HIV-Positive People, Report Says: ‘Of Great Concern’January 24th, 2024